FDA Adverse Event Injury Summary report: N

AXERA 2 ACCESS SYSTEM

MDR report key: 2881568 · Received December 18, 2012

Report

Report Number
3008493244-2012-00039
Event Type
Injury
Date Received
December 18, 2012
Report Date
November 26, 2012
Manufacturer
ARSTASIS INC.
Product Code
DYB
PMA / PMN Number
K121521
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED; THEREFORE, PRODUCT FAILURE ANALYSIS WAS NOT POSSIBLE. THE LOT NUMBER WAS NOT REPORTED AND COULD NOT BE DISTINGUISHED FROM MULTIPLE LOTS SHIPPED TO THE FACILITY. THEREFORE, A REVIEW OF THE DEVICE HISTORY RECORD FOR THIS LOT WAS NOT PERFORMED. ATTEMPTS TO RETRIEVE ADDITIONAL INFORMATION, SUCH AS PATIENT INFORMATION, WERE UNANSWERED BY THE FACILITY, DUE TO A TURNOVER IN STAFF. THE AXERA 2 ACCESS SYSTEM INSTRUCTIONS FOR USE (IFU), WAS REVIEWED. DISSECTION IS A KNOWN POSSIBLE ADVERSE EFFECT SECTION OF THE PRODUCT IFU. THE IFU PROVIDES THE APPROPRIATE INSTRUCTIONS ON DEVICE USAGE, WARNINGS AND PRECAUTIONS; THEREFORE, NO UPDATE IS REQUIRED. BASED ON THE REVIEW COMPLETED, IT IS UNKNOWN WHETHER OR NOT THE DEVICE WAS OUT OF SPECIFICATION AS IT CANNOT BE DEFINITIVELY DETERMINED. THE ROOT CAUSE, BASED ON AVAILABLE INFORMATION, IS UNKNOWN AS IT CANNOT BE DEFINITIVELY DETERMINED.

Description of Event or Problem · 1

THE PHYSICIAN WAS IN TRAINING AND PERFORMING HIS 3RD CASE WITH THE DEVICE. HE ATTEMPTED TO ADVANCE THE 0.035" LATCHWIRE WITHOUT SUCCESS. A SECOND PHYSICIAN TOOK OVER AND AN ANGIOGRAM PERFORMED REVEALED A DISSECTION. THE PHYSICIAN INSERTED A DILATOR FOLLOWED BY A GUIDEWIRE AND WAS ABLE TO TRAVERSE WITH GUIDEWIRE AND PERFORM A LONG-BALLOON ANGIOPLASTY, WHICH RESOLVED THE DISSECTION. THE PATIENT RECOVERED WITH NO FURTHER SEQUELAE AND WAS DISCHARGED THE FOLLOWING DAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 AXERA 2 ACCESS SYSTEM INTRODUCER CATHETER DYB ARSTASIS INC. UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Hospitalization| R